Answer Capsule
If insurance denied your GLP-1 coverage, you still have three main options: appeal or retry prior authorization, compare cash-pay compounded GLP-1 programs, or pay cash for FDA-approved brand-name medication. The best path depends on why coverage was denied, your medical history, your budget, and whether you are comfortable with compounded medication.
Start by asking the provider or insurer why coverage was denied. If documentation or prior authorization support could change the answer, an insurance-aware program may help. If coverage is unlikely, compare cash-pay programs where the medication price is clear before you enroll.
Do not assume a denial means you should buy medication from a no-prescription seller. A licensed clinician should still decide whether a GLP-1 is appropriate.
Path 1: Appeal or Retry Prior Authorization
If your insurance denied coverage, ask for the denial reason in writing. Common categories include missing documentation, plan exclusion, step-therapy requirements, diagnosis mismatch, or prior authorization criteria that were not met.
An appeal may be worth trying if:
- Your BMI or diagnosis meets the plan’s criteria
- Your provider can document prior attempts at weight management
- You have related medical conditions that may support coverage
- The denial was based on missing paperwork
- Your plan covers the medication under certain conditions
Ro Body Program is a relevant comparison point here because Ro states its membership includes insurance support and prior authorization help. That does not mean coverage is guaranteed. Appeals often fail when the medication is excluded or the plan criteria are strict.
Path 2: Cash-Pay Compounded GLP-1 Programs
If insurance is not realistic, cash-pay compounded programs may offer more predictable pricing. This path is often chosen by readers who do not qualify for coverage, have an exclusion for weight-loss medications, or want a simpler monthly quote.
Programs to compare include Henry Meds, Mochi Health, Direct Meds, TMates, Sprout Health, Embody, and Care Bare Rx.
The key question is whether the listed price includes medication. Some programs include medication in the subscription if prescribed. Others charge a membership fee and add medication separately.
Path 3: Brand-Name GLP-1 Cash Pay
If you want an FDA-approved brand-name GLP-1 but insurance will not pay, you may be able to pay cash. This path can be significantly more expensive than compounded options, but it may be preferable if FDA-approved medication matters most to you.
Ro lists FDA-approved options and separates membership cost from medication cost. That structure can work for readers who want brand-name access and support, but the total price may be much higher than the membership fee alone.
Cost Comparison After Insurance Denial
Prices below come from RY Verified Facts — GLP-1 Providers, auto-refreshed July 10, 2026 at 17:26 PT from the verified provider source of truth. Verification dates are shown by provider.
| Provider | Best post-denial path | Verified price | Medication included? | Verified |
|---|---|---|---|---|
| Ro Body Program | Retry insurance or choose brand-name cash-pay path | Membership $149/mo, $74/mo with annual prepay, $39 first month; Wegovy pill from $149 first month then $199–$299/mo, billed separately; Zepbound KwikPen from $299 first month then $399–$449/mo, billed separately | No. Membership plus medication. | Jul 3, 2026 |
| Mochi Health | Membership plus separate compounded medication cost | Membership $79/mo + compounded semaglutide $99/mo or compounded tirzepatide $199/mo, all doses | No. Membership plus medication. | Jul 3, 2026 |
| Henry Meds | Cash-pay compounded medication path | Semaglutide from $179/mo; tirzepatide from $179/mo | Yes, medication included | Jul 9, 2026 |
| Direct Meds | Cash-pay compounded comparison | Semaglutide from $179.10/mo sublingual to $297/mo injection; tirzepatide from $224.10/mo sublingual to $399/mo injection | Yes, all-inclusive | Jul 3, 2026 |
| TMates | Cash-pay compounded comparison | Semaglutide from $158/mo and tirzepatide from $167/mo with advertised $100-off promotion | Yes, visits and medication included | Jul 9, 2026 |
| Sprout Health | Cash-pay GLP-1 comparison | Semaglutide from $149/mo; tirzepatide from $199/mo | Yes, medication included | Jul 3, 2026 |
| Embody | Cash-pay GLP-1 comparison | Semaglutide from $99/mo promotional rate; tirzepatide flat rate not publicly listed, $250-off promotion advertised | Yes, medication and visits included | Jul 9, 2026 |
| Care Bare Rx | Budget cash-pay comparison | Semaglutide from $199/mo; tirzepatide from $199/mo | Yes, medication included | May 7, 2026 |
What to Do Before Switching to Cash Pay
Before giving up on insurance entirely:
- Ask for the denial reason.
- Ask whether your provider can submit missing documentation.
- Ask whether a different GLP-1 is covered.
- Ask whether step therapy is required.
- Compare membership fees separately from medication costs.
- Compare compounded and brand-name options separately.
- Confirm cancellation terms before paying for prepaid plans.
For more pricing context, compare the GLP-1 Price Index and the RangeYourself guide to getting GLP-1s without insurance.
Safety Note on Compounded GLP-1s
Compounded semaglutide and compounded tirzepatide are not FDA-approved versions of brand-name medications. The FDA says compounded drugs are not reviewed for safety, effectiveness, or quality before marketing. GLP-1 medications are not appropriate for everyone — including, per FDA labeling for semaglutide and tirzepatide, people with a personal or family history of medullary thyroid carcinoma or MEN2 — and side effects can include nausea, vomiting, diarrhea, constipation, abdominal pain, and dehydration.
If you choose a compounded cash-pay path, ask which pharmacy fills the prescription, whether the pharmacy is licensed in your state, what active ingredient is used, how dosing is measured, and who handles side effects.
Do not buy GLP-1 medication from a no-prescription seller or a site selling research-use peptides.
FAQ
Can I appeal a GLP-1 insurance denial?
Yes, in many cases you can appeal or resubmit prior authorization. Success depends on your plan, diagnosis, documentation, and coverage rules.
What if my plan excludes weight-loss medications?
If the plan excludes the drug category, appeals may be difficult. Cash-pay compounded options or brand-name cash pay may be alternatives.
Is compounded semaglutide safer than brand-name medication?
Not necessarily. Compounded semaglutide is not FDA-approved and is not reviewed by FDA for safety, effectiveness, or quality before marketing.
Should I use Ro after an insurance denial?
Ro may be relevant if you want insurance support or a brand-name pathway, but its membership price does not include medication.
Which provider is cheapest if insurance denies coverage?
The cheapest provider depends on current pricing, medication type, and whether medication is included. Compare total monthly cost, not only membership fees.
Sources Checked
- RY Verified Facts — GLP-1 Providers, auto-refreshed July 10, 2026 at 17:26 PT; provider verification dates shown individually in the table.
- FDA: “FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss,” content current as of June 15, 2026.
RangeYourself may earn a commission if you sign up through links on this page — see how we make money. Rankings and verdicts are based on verified pricing and program structure, never on commissions. Prices change frequently — always confirm current rates on each provider’s website before purchasing.
RangeYourself is reader-supported. We may earn a commission when you click on certain links — at no extra cost to you. Editorial recommendations are made independently. Last reviewed July 11, 2026.
